Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES

NCT03236415 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Global sales of the Absorb BVS halted effective September 14, 2017.

Conditions

Coronary Artery Disease
Diabetes Mellitus

Interventions

DEVICE: Xience Drug Eluting Stent
DEVICE: ABSORB Bioresorbable Vascular Scaffold

Sponsor

Ottawa Heart Institute Research Corporation